With RSV immunisations now available, Australia has a real opportunity to reduce severe illness.

Unite Against RSV is driving progress by supporting awareness, acceptance and equitable access to protection for babies, older adults and those at highest risk.

RSV IN AUSTRALIA

RSV is a highly contagious and potentially dangerous respiratory virus that causes seasonal outbreaks and spikes in hospital admissions, usually during the winter months. While most cases of RSV are mild, it can lead to lung infections such as bronchiolitis or pneumonia in children, older adults, and people with underlying health conditions. Historically, RSV has placed a massive burden on Australian communities every year. 

RSV has the greatest impact on the oldest and youngest members of our community, and is the number one cause of hospitalisation of Australian infants. Without immunisations, the unpredictable virus puts thousands of infants in hospital each year and can cause serious long-term health issues. It is also an under-recognised cause of illness in older people, where it can cause infections in the airways, hospitalisation, and even death. 

RSV protection is now a reality. RSV preventative therapies that have been proven to prevent severe lower respiratory tract disease and reduce hospitalisation rates are now available. These immunisations are used to protect infants (administered directly or via the mother during pregnancy), as well as older adults and people with underlying health conditions. 

STORIES

Every year, thousands of Australian families are impacted by RSV-related illness, with memories often lasting a lifetime.  

Here’s just a small selection of these countless stories.  

ABOUT UNITE AGAINST RSV

Through the Unite Against RSV campaign, the Immunisation Foundation of Australia supports

RSV Resources

Individuals and organisations can Unite Against RSV by helping raise awareness, advocating for access and supporting acceptance of RSV protection. Find out more here.

Find out more about RSV

THIS CAMPAIGN IS SUPPORTED THROUGH UNRESTRICTED EDUCATIONAL GRANTS FROM GSK AUSTRALIA, PFIZER AUSTRALIA AND SANOFI AUSTRALIA & NEW ZEALAND.